Anti-Coagulants, Corticosteroids Now Mainstay of COVID-19 Therapy for Moderate and Severe Cases, Says Health Ministry As Total Recovery Crosses 5 Lakh

Team Latestly

New Delhi, July 11: The Ministry of Health and Family Welfare on Saturday informed that India's novel coronavirus recovery rate has improved to 62.78 percent. For moderate and severe cases, the ministry said that the patient should be provided adequate oxygen support and appropriate and timely administration of anti-coagulants and widely available and inexpensive corticosteroids in accordance with the protocol. The drugs can be considered to be the mainstay of COVID-19 therapy, the government said.

Also Read | Truck Carrying Chemical Methyl Methacrylate Overturns on Ghodbunder Road in Thane: Live News Breaking & Coronavirus Updates on July 11, 2020

The Health Ministry said that the total recovered cases have crossed the five lakh mark. Till now, 5,15,385 individuals have been cured. The recovered cases have outnumbered active cases by 2,31,978. Over 22,000 people also died from the infection in the country. India Reports Highest Single-Day Spike of 27,114 New COVID-19 Cases in Past 24 Hours, Tally Crosses 8 Lakh-Mark, Death Toll Rises to 22,123.

ANI Tweet:

Also Read | Hemant Soren Coronavirus Test Results: Jharkhand CM Tests Negative For COVID-19


"Total recovered cases among COVID-19 patients crossed the 5 lakh mark today. 5,15,385 COVID-19 patients have so far been cured. Recovered cases outnumber COVID-19 active cases by 2,31,978. The recovery rate has further improved to 62.78%," the Health Ministry said.

According to the latest Union Health Ministry update, the COVID-19 cases in India has surged to 8,20,916. Of the total cases, 2,83,407 are active, while 5,15.386 have recovered from the illness. Till now, the infection has also claimed 22,123 lives.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting.